Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation

Journal of Clinical Microbiology

Volumn 34, Issue 11, 1996, Pages 2702-2706

  Mayerat, Claude ^a   Bürgisser, Philippe ^a   Lavanchy, Daniel ^a   Mantegani, Alain ^a   Frei, Philippe Charles ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ARTICLE; CHRONIC HEPATITIS; DIAGNOSTIC ACCURACY; HEPATITIS C VIRUS; LIVER CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS DETECTION;

HEPATITIS C VIRUS;

EID: 0029910655     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.11.2702-2706.1996     Document Type: Article

References (21)

1. Aiyamata, T., K. Yoshiota, H. Hirofuji, A. Kusakabe, M. Yamada, K. Tanaka, and S. Kamunu. 1994. Changes in scrum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 39:2244-2249.
2. Bresters, D., H. T. M. Cuypers, H. W. Reesink, E. P. Mauser-Bunschoten, H. M. van den Berg, W. P. Schaasberg, J. C. Wilber, M. S. Urdea, P. Neuwald, and P. N. Lelie. 1994. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial. J. Med. Virol. 43:262-268.
3. Bresters, D., E. P. Mauser-Bunschoten, H. T. M. Cuypers, P. N. Lelie, J. H. Han, P. L. M. Jansen, M. Houghton, and H. W. Reesink. 1992. Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in haemophilia patients. Scand. J. Gastroenterol. 27:166-168.
4. Bukh, J., R. H. Purcell, and R. H. Miller. 1992. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. USA 89:4942-4946.
5. Chomczyniski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
6. Choo, Q. L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, D. Medina-Selby, and P. J. Barr. 1991. Genetic organization and diversity of hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455.
7. Collins, M. L., C. Zayati, J. J. Detmer, J. A. Kolberb, T.-A. Cha, B. D. Irvine, J. Tucker, and M. S. Urdea. 1995. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal. Biochem. 226:120-129.
8. Di Bisceglie, A. M., P. Martin, C. Kassianides, M. Lisker-Melman, L. Murray, J. Waggoner, Z. Goodman, S. M. Banks, and J. H. Hoofnagle. 1989. Recombinant interferon alpha therapy for chronic hepatitis C. N. Engl. J. Med. 321:1506-1510.
9. Garson, J. A., P. W. Tuke, C. Ring, and R. S. Tedder. 1990. Enhanced detection by PCR of hepatitis C virus RNA. Lancet 336:878-879.
10. Gretch, D., L. Corey, J. Wilson, C. dela Rosa, R. Wilson, R. L. Carithers, Jr., M. Bush, J. Hart, M. Sayers, and J. Han. 1994. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high titer viremia correlates with advanced stage of disease. J. Infect. Dis. 169:1219-1225.
11. Gretch, D. R., C. dela Rosa, R. L. Carithers, Jr., R. A. Willson, B. Williams, and L. Corey. 1995. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann. Intern. Med. 123:321-329.
12. Han, J. H., V. Shyamala, K. H. Richman, M. J. Brauer, B. Irvine, M. S. Urdea, P. Tekamp-Olson, G. Kuo, Q. L. Choo, and M. Houghton. 1991. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc. Natl. Acad. Sci. USA 88:1711-1715.
13. Jalava, T., P. Lehtivaara, A. Kallio, M. Ranki, and H. Söderlund. 1993. Quantification of hepatitis B virus DNA by competitive amplification and hybridization on microplates. BioTechniques 15:134-139.
14. Lau, J. Y., G. L. Davis, J. Knifen, K. P. Qian, M. S. Urdea, C. S. Chan, M. Mizokami, P. D. Neuwald, and C. Wilber. 1993. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504.
15. Lau, J. Y. N., P. Simmonds, and M. S. Urdea. 1995. Implication of variations of "conserved" regions of hepatitis C virus genome. Lancet 346:425-426.
16. Marcellin, P., N. Boyer, E. Giostra, C. Degott, A. M. Couroucé, F. Degos, H. Coppere, P. Cales, P. Couzigou, and J. P. Benhamou. 1991. Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 13:393-397.
17. Onto, E., M. Mizokami, T. Nakano, H. Terashima, O. Nojiri, K. Sakakibara, M. Mizuno, M. Ogino, M. Nakamura, and Y. Matsumoto. 1994. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C. J. Med. Virol. 44:410-414.
18. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
19. Shindo, M., A. M. di Bisceglie, L. Cheung, W. K. Shih, K. Cristiano, S. M. Feinstone, and J. H. Hoofnagle. 1991. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann. Intern. Med. 115:700-704.
20. Urdea, M. S., T. Horn, T. J. Fultz, M. Anderson, M. Running, S. Harem, D. Ahle, and C. A. Chang. 1991. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Symp. Ser. 24:197-200.
21. Young, K. Y., R. M. Resnick, and T. W. Myers. 1993. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J. Clin. Microbiol. 31:882-886.